Andrew apologised for the delay in replying. Reporting season has been very busy.
I had two issues, both centering around communication.
The first was the investment briefing. I felt that other companies allowed small investors to listen in to these.
AH said that starting from the next half, they would hold their own conference call, so we would be able to register for that. This is very important to me, as you gain so much information from listening to the analysts and the answers given to them
My second issue was the lack of info on progress with China.
The institutions seem to have little interest in this viewing it as a blue sky potential, so I think that is why there wasn't a focus on it in the last report. It certainly isn't dead, just proving slower and more difficult than perhaps first anticipated. They are dealing with enormous state institutions in order to create a private market model. I would imagine over the last year the macro environment in China has been particularly difficult.
They have been working with Enlitic in the background with the financing and hope that will be successfully completed soon. They are also planning to have it deployed operationally in their network.
I felt all very positive. I am happy with the progress in Australia and it is good to hear that the other bits are still progressing. China is such a wildcard - has enormous potential, but I can see ow it would be challenging to get it started, especially with Xi Jinping centralising control again.
- Forums
- ASX - By Stock
- Ann: Additional MRI Medicare Licence Process
Andrew apologised for the delay in replying. Reporting season...
-
- There are more pages in this discussion • 15 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add CAJ (ASX) to my watchlist
(20min delay)
|
|||||
Last
38.0¢ |
Change
0.020(5.56%) |
Mkt cap ! $341.1M |
Open | High | Low | Value | Volume |
36.5¢ | 38.0¢ | 36.5¢ | $366.6K | 980.1K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
1 | 1394 | 37.0¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
38.0¢ | 193185 | 6 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
5 | 335146 | 0.205 |
4 | 294750 | 0.200 |
9 | 662563 | 0.195 |
7 | 1086315 | 0.190 |
4 | 104210 | 0.185 |
Price($) | Vol. | No. |
---|---|---|
0.215 | 360292 | 5 |
0.220 | 318014 | 13 |
0.225 | 188194 | 5 |
0.230 | 1008000 | 2 |
0.235 | 45245 | 2 |
Last trade - 16.10pm 25/11/2024 (20 minute delay) ? |
Featured News
CAJ (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Andy Udell, CCO
Andy Udell
CCO
SPONSORED BY The Market Online